{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T14:46:51Z","timestamp":1766587611383},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,3,27]],"date-time":"2010-03-27T00:00:00Z","timestamp":1269648000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1007\/s00213-010-1821-z","type":"journal-article","created":{"date-parts":[[2010,3,26]],"date-time":"2010-03-26T08:17:12Z","timestamp":1269591432000},"page":"97-106","source":"Crossref","is-referenced-by-count":19,"title":["Cannabis constituents modulate \u22069-tetrahydrocannabinol-induced hyperphagia in rats"],"prefix":"10.1007","volume":"210","author":[{"given":"Jonathan A.","family":"Farrimond","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin J.","family":"Whalley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire M.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,3,27]]},"reference":[{"key":"1821_CR1","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1467-789X.2008.00520.x","volume":"10","author":"F Akbas","year":"2008","unstructured":"Akbas F, Gasteyger C, Sj\u00f6din A, Astrup A, Larsen TM (2008) A critical review of the cannabinoid receptor as a drug target for obesity management. Obes Rev 10:58\u201367","journal-title":"Obes Rev"},{"key":"1821_CR2","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1200\/JCO.1994.12.7.1524","volume":"12","author":"JA Beal","year":"1994","unstructured":"Beal JA (1994) Appetite effect of dronabinol. J Clin Oncol 12:1524\u20131525","journal-title":"J Clin Oncol"},{"key":"1821_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jep.2006.02.001","volume":"105","author":"M Ben Amar","year":"2006","unstructured":"Ben Amar M (2006) Cannabinoids in medicine: a review of their therapeutic potential. J Ethnopharmacol 105:1\u201325","journal-title":"J Ethnopharmacol"},{"key":"1821_CR4","first-page":"19","volume-title":"Behavioural flux and feeding: continuous monitoring of food intake and food selection, and the video-recording of appetitive and satiety sequences for the analysis of drug action. Anorectic agents: mechanism of action and tolerance","author":"JE Blundell","year":"1978","unstructured":"Blundell JE, McArthur RA (1978) Behavioural flux and feeding: continuous monitoring of food intake and food selection, and the video-recording of appetitive and satiety sequences for the analysis of drug action. Anorectic agents: mechanism of action and tolerance. Raven Press, New York, pp 19\u201343"},{"key":"1821_CR5","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/sj.bjp.0707481","volume":"152","author":"AJ Brown","year":"2007","unstructured":"Brown AJ (2007) Novel cannabinoid receptors. Brit J Pharmacol 152:567\u2013575","journal-title":"Brit J Pharmacol"},{"key":"1821_CR6","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1016\/S0014-2999(97)00146-5","volume":"323","author":"TH Burkey","year":"1997","unstructured":"Burkey TH, Quock RM, Consroe P, Roeske WR, Yamamura HI (1997) \u22069-Tetrahydrocannabinol is a partial agonist of cannabinoid receptors in mouse brain. Eur J Pharmacol 323:R3\u2013R4","journal-title":"Eur J Pharmacol"},{"key":"1821_CR7","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.nutres.2008.08.003","volume":"28","author":"TP Carr","year":"2008","unstructured":"Carr TP, Jesch ED, Brown AW (2008) Endocannabinoids, metabolic regulation, and the role of diet. Nutr Res 28:641\u2013650","journal-title":"Nutr Res"},{"key":"1821_CR8","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1038\/bjp.2008.190","volume":"154","author":"I Dennis","year":"2008","unstructured":"Dennis I, Whalley BJ, Stephens GJ (2008) Effects of \u22069-tetrahydrocannabivarin on [35S] GTP\u03b3S binding in mouse brain cerebellum and piriform cortex membranes. Brit J Pharmacol 154:1349\u20131358","journal-title":"Brit J Pharmacol"},{"key":"1821_CR9","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1124\/jpet.107.134809","volume":"325","author":"L Petrocellis De","year":"2008","unstructured":"De Petrocellis L, Vellani V, Schiano-Moriello A, Marini P, Magherini PC, Orlando P, Di Marzo V (2008) Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8. J Pharmacol Exp Ther 325: 1007\u20131015","journal-title":"J Pharmacol Exp Ther"},{"key":"1821_CR10","first-page":"317","volume-title":"Cannabinoid stereoisomers: pharmacological effects. Handbook of stereoisomers: drugs in psychopharmacology","author":"WL Dewey","year":"1984","unstructured":"Dewey WL, Martin BR, May EL (1984) Cannabinoid stereoisomers: pharmacological effects. Handbook of stereoisomers: drugs in psychopharmacology. CPC Press, Boca Raton, pp 317\u2013326"},{"key":"1821_CR11","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrd1495","volume":"3","author":"V Marzo Di","year":"2004","unstructured":"Di Marzo V, Bifulco M, De Petrocellis L (2004) The endocannabinoid system and its therapeutic exploitation. Nat Rev Drug Discov 3:771\u2013784","journal-title":"Nat Rev Drug Discov"},{"key":"1821_CR12","doi-asserted-by":"crossref","first-page":"9702","DOI":"10.1523\/JNEUROSCI.1171-08.2008","volume":"28","author":"NV Patrizio Di","year":"2008","unstructured":"Di Patrizio NV, Simansky KJ (2008) Activating parabrachial cannabinoid CB1 receptors selectively stimulates feeding of palatable foods in rats. J Neurosci 28:9702\u20139709","journal-title":"J Neurosci"},{"key":"1821_CR13","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.lfs.2005.09.011","volume":"78","author":"MA Elsohly","year":"2005","unstructured":"Elsohly MA, Slade D (2005) Chemical constituents of marijuana: the complex mixture of natural cannabinoids. Life Sci 78:539\u2013548","journal-title":"Life Sci"},{"key":"1821_CR14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0014-5793(87)81420-5","volume":"211","author":"AT Evans","year":"1987","unstructured":"Evans AT, Formukong E, Evans FJ (1987) Activation of phospholipase A2 by cannabinoids. Lack of correlation with CNS effects. FEBS Lett 211: 119\u2013122","journal-title":"FEBS Lett"},{"key":"1821_CR15","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s002130050893","volume":"142","author":"JE Gallate","year":"1999","unstructured":"Gallate JE, McGregor IS (1999) The motivation for beer in rats: effects of ritanserin, naloxone and SR141716. Psychopharmacology 142:302\u2013308","journal-title":"Psychopharmacology"},{"key":"1821_CR16","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0014-2999(99)00170-3","volume":"370","author":"JE Gallate","year":"1999","unstructured":"Gallate JE, Saharov T, Mallet PE, McGregor IS (1999) Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist. Eur J Pharmacol 370:233\u2013240","journal-title":"Eur J Pharmacol"},{"key":"1821_CR17","first-page":"10","volume":"1","author":"F Grotenhermen","year":"2006","unstructured":"Grotenhermen F (2006) Cannabinoids and the endocannabinoid system. Cannabinoids 1:10\u201314","journal-title":"Cannabinoids"},{"key":"1821_CR18","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s00213-005-2242-2","volume":"181","author":"M Haney","year":"2005","unstructured":"Haney M, Rabkin J, Gunderson E, Foltin RW (2005) Dronabinol and marijuana in HIV\u2009+\u2009marijuana smokers: acute effects on caloric intake and mood. Psychopharmacology 181:170\u2013178","journal-title":"Psychopharmacology"},{"key":"1821_CR19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0014-2999(00)00059-5","volume":"392","author":"S Hao","year":"2000","unstructured":"Hao S, Avraham Y, Mechoulam R, Berry EM (2000) Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice. Eur J Pharmacol 392:147\u2013156","journal-title":"Eur J Pharmacol"},{"key":"1821_CR20","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1523\/JNEUROSCI.11-02-00563.1991","volume":"11","author":"M Herkenham","year":"1991","unstructured":"Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, Rice KC (1991) Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci 11:563\u2013583","journal-title":"J Neurosci"},{"key":"1821_CR21","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejphar.2008.06.079","volume":"591","author":"ML Holland","year":"2008","unstructured":"Holland ML, Allen JD, Arnold JC (2008) Interaction of plant cannabinoids with the multidrug transporter ABCC1 (MRP1). Eur J Pharmacol 591:128\u2013131","journal-title":"Eur J Pharmacol"},{"key":"1821_CR22","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.tips.2009.07.006","volume":"30","author":"AA Izzo","year":"2009","unstructured":"Izzo AA, Borrelli F, Capasso R, Di Marzo V, Mechoulam R (2009) Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends Pharmacol Sci 30:515\u2013527","journal-title":"Trends Pharmacol Sci"},{"key":"1821_CR23","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/nrd2775","volume":"7","author":"D Jones","year":"2008","unstructured":"Jones D (2008) End of the line for cannabinoid receptor 1 as an anti-obesity target? Nat Rev Drug Discov 7:961\u2013962","journal-title":"Nat Rev Drug Discov"},{"key":"1821_CR24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0195-6663(84)80049-5","volume":"5","author":"TC Kirkham","year":"1984","unstructured":"Kirkham TC, Blundell JE (1984) Dual action of naloxone on feeding revealed by behavioural analysis: separate effects on initiation and termination of eating. Appetite 5:45","journal-title":"Appetite"},{"key":"1821_CR25","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1079\/095442201108729141","volume":"14","author":"TC Kirkham","year":"2001","unstructured":"Kirkham TC, Williams CM (2001) Endogenous cannabinoids and appetite. Nutr Res 14:65\u201386","journal-title":"Nutr Res"},{"key":"1821_CR26","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ceca.2009.07.007","volume":"46","author":"N Lozovaya","year":"2009","unstructured":"Lozovaya N, Min R, Tsintsadze V, Burnashev N (2009) Dual modulation of CNS voltage-gated calcium channels by cannabinoids: focus on CB1 receptor-independent effects. Cell Calcium 46:154\u2013162","journal-title":"Cell Calcium"},{"key":"1821_CR27","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/bjp.2008.57","volume":"154","author":"YL Ma","year":"2008","unstructured":"Ma YL, Weston SE, Whalley BJ, Stephens GJ (2008) The phytocannabinoid \u22069-tetrahydrocannabivarin modulates inhibitory neurotransmission in the cerebellum. Brit J Pharmacol 154:204\u2013215","journal-title":"Brit J Pharmacol"},{"key":"1821_CR28","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1124\/mol.107.041863","volume":"73","author":"D McHugh","year":"2008","unstructured":"McHugh D, Tanner C, Mechoulam R, Pertwee RG, Ross RA (2008) Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids: evidence for a site distinct from CB1 and CB2. Mol Pharmacol 73:441\u2013450","journal-title":"Mol Pharmacol"},{"key":"1821_CR29","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S0040-4039(00)90646-4","volume":"12","author":"R Mechoulam","year":"1967","unstructured":"Mechoulam R, Gaoni Y (1967) The absolute configuration of \u22061-tetrahydrocannabinol, the major active constituent of hashish. Tetrahedron Lett 12:1109\u20131111","journal-title":"Tetrahedron Lett"},{"key":"1821_CR30","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(07)61162-3","volume":"370","author":"THM Moore","year":"2007","unstructured":"Moore THM, Zammit S, Lingford-Hughes A, Barnes TRE, Jones PB, Burke M, Lewis G (2007) Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 370:319\u2013328","journal-title":"Lancet"},{"key":"1821_CR31","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/sj.ijo.0803784","volume":"32","author":"M Neovius","year":"2007","unstructured":"Neovius M, Teixeira-Pinto A, Rasmussen F (2007) Shift in the composition of obesity in young adult men in Sweden over a third of a century. Int J Obes 32:832\u2013836","journal-title":"Int J Obes"},{"key":"1821_CR32","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","volume":"153","author":"RG Pertwee","year":"2007","unstructured":"Pertwee RG (2007) The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: \u22069-tetrahydrocannabinol, cannabidiol and \u22069-tetrahydrocannabivarin. Brit J Pharmacol 153:199\u2013215","journal-title":"Brit J Pharmacol"},{"key":"1821_CR33","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","volume":"153","author":"RG Pertwee","year":"2008","unstructured":"Pertwee RG (2008a) The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: \u22069-tetrahydrocannabinol, cannabidiol and \u22069-tetrahydrocannabivarin. Brit J Pharmacol 153:199\u2013215","journal-title":"Brit J Pharmacol"},{"key":"1821_CR34","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1369-1600.2008.00108.x","volume":"13","author":"RG Pertwee","year":"2008","unstructured":"Pertwee RG (2008b) Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond. Addict Biol 13:147\u2013159","journal-title":"Addict Biol"},{"key":"1821_CR35","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1124\/jpet.105.100503","volume":"317","author":"GK Rao","year":"2006","unstructured":"Rao GK, Kaminski NE (2006) Cannabinoid-mediated elevation of intracellular calcium: a structure-activity relationship. J Pharmacol Exp Ther 317:820\u2013829","journal-title":"J Pharmacol Exp Ther"},{"key":"1821_CR36","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/j.1476-5381.2008.00107.x","volume":"156","author":"G Riedel","year":"2009","unstructured":"Riedel G, Fadda P, McKillop-Smith PRG, Platt B, Robinson L (2009) Synthetic and plant-derived cannabinoid receptor antagonists show hypophagic properties in fasted and non-fasted mice. Brit J Pharmacol 156:1154\u20131166","journal-title":"Brit J Pharmacol"},{"key":"1821_CR37","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1523\/JNEUROSCI.4212-08.2009","volume":"29","author":"D Ryan","year":"2009","unstructured":"Ryan D, Drysdale AJ, Lafourcade C, Pertwee RG, Platt B (2009) Cannabidiol targets mitochondria to regulate intracellular Ca2+ levels. J Neurosci 29:2053","journal-title":"J Neurosci"},{"key":"1821_CR38","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1124\/dmd.108.020909","volume":"36","author":"S Takeda","year":"2008","unstructured":"Takeda S, Misawa K, Yamamoto I, Watanabe K (2008) Cannabidiolic acid as a selective cyclooxygenase-2 inhibitory component in cannabis. Drug Metab Dispos 36:1917\u20131921","journal-title":"Drug Metab Dispos"},{"key":"1821_CR39","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/sj.bjp.0706414","volume":"7","author":"A Thomas","year":"2005","unstructured":"Thomas A, Stevenson LA, Wease KN, Price MR, Baillie G, Ross RA, Pertwee RG (2005) Evidence that the plant cannabinoid \u22069-tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonist. Brit J Pharmacol 7:917\u2013926","journal-title":"Brit J Pharmacol"},{"key":"1821_CR40","unstructured":"Weston SE, Williamson EM, Constanti A, Stephens GJ, Whalley BJ (2006) Tetrahydrocannabivarin exhibits anticonvulsant effects in a piriform cortical brain slice model of epileptiform activity. Proceedings of the BPS at http:\/\/www.pa2online.org\/abstract\/abstract.jsp?abid=28533"},{"key":"1821_CR41","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.neulet.2004.04.044","volume":"365","author":"BJ Whalley","year":"2004","unstructured":"Whalley BJ, Wilkinson JD, Williamson EM, Constanti A (2004) A novel component of cannabis extract potentiates excitatory synaptic transmission in rat olfactory cortex in vitro. Neurosci Lett 365:58\u201363","journal-title":"Neurosci Lett"},{"key":"1821_CR42","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s002130050953","volume":"143","author":"CM Williams","year":"1999","unstructured":"Williams CM, Kirkham TC (1999) Anandamide induces overeating: mediation by central cannabinoid CB1 receptors. Psychopharmacology 143:315\u2013317","journal-title":"Psychopharmacology"},{"key":"1821_CR43","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0031-9384(02)00725-4","volume":"76","author":"CM Williams","year":"2002","unstructured":"Williams CM, Kirkham TC (2002) Observational analysis of feeding induced by \u22069-THC and anandamide. Physiol Behav 76:241\u2013250","journal-title":"Physiol Behav"},{"key":"1821_CR44","unstructured":"Williams CM, Kirkham TC (in press) Accumbens shell infusion of the endocannabinoid 2-AG increases food intake by advancing meal-onset in free-feeding rats. Psychopharmacology"},{"key":"1821_CR45","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0031-9384(98)00170-X","volume":"65","author":"CM Williams","year":"1998","unstructured":"Williams CM, Rogers PJ, Kirkham TC (1998) Hyperphagia in pre-fed rats following oral \u22069-THC. Physiol Behav 65:343\u2013346","journal-title":"Physiol Behav"},{"key":"1821_CR46","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.2165\/00003495-200060060-00005","volume":"60","author":"EM Williamson","year":"2000","unstructured":"Williamson EM, Evans FJ (2000) Cannabinoids in clinical practice. Drugs 60:1303\u20131314","journal-title":"Drugs"},{"key":"1821_CR47","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/0024-3205(80)90631-1","volume":"26","author":"PW Wirth","year":"1980","unstructured":"Wirth PW, Watson ES, ElSohly M, Turner CE, Murphy JC (1980) Anti-inflammatory properties of cannabichromene. Life Sci 26:1991\u20131995","journal-title":"Life Sci"},{"key":"1821_CR48","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1124\/jpet.105.098541","volume":"317","author":"HJ Zhu","year":"2006","unstructured":"Zhu HJ, Wang JS, Markowitz JS, Donovan JL, Gibson BB, Gefroh HA, Devane CL (2006) Characterization of P-glycoprotein inhibition by major cannabinoids from marijuana. J Pharmacol Exp Ther 317:850\u2013857","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-010-1821-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-010-1821-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-010-1821-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T20:07:12Z","timestamp":1558642032000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-010-1821-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,27]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["1821"],"URL":"https:\/\/doi.org\/10.1007\/s00213-010-1821-z","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,27]]}}}